Jason Wustner

A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors

Luis A. Díaz, Christina Coughlin, Susan C. Weil et al. · Clinical Cancer Research · 2014 · 57 citations · Full text

Medicine, Oncology, Pharmacology +15

Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection

Tomasz J. Wąsik, Paweł P. Jagodzińśki, Elizabeth Hyjek et al. · The Journal of Immunology · 1997 · 49 citations

Life Sciences, Immunology, Infectious Diseases +15

Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature

Katherine A. Rybinski, Hongxia Z. Imtiyaz, Barrie Mittica et al. · Oncotarget · 2015 · 48 citations · Full text

Medicine, Cell Biology, Oncology +15

Role of the V2, V3, and CD4-Binding Domains of GP120 in Curdlan Sulfate Neutralization Sensitivity of HIV-1 during Infection of T Lymphocytes

Paweł P. Jagodzińśki, Jason Wustner, Dariusz Kmieciak et al. · Virology · 1996 · 31 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer

Colm Farrell, Charles Schweizer, Jason Wustner et al. · Cancer Chemotherapy and Pharmacology · 2012 · 21 citations · Full text

Pharmacy, Oncology, Pharmacology +12